Search

Your search keyword '"Galli E."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Galli E." Remove constraint Author: "Galli E." Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
35 results on '"Galli E."'

Search Results

1. First‐line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real‐life study on 547 patients to evaluate the long‐term efficacy and tolerability of different chemoimmunotherapy strategies.

2. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics

3. The Italian CART‐SIE real life multicenter observational study on Chimeric Antigen Receptor T‐cell (CAR‐T) therapy for large B‐cell (LBCL) and mantle cell (MCL) lymphomas.

4. CART‐SIE REAL LIFE STUDY: PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) HAVE A SUPERIOR OUTCOME COMPARED TO LARGE B‐CELL LYMPHOMA (LBCL) TREATED WITH AXICABTAGENE CILOLEUCEL.

6. C4-consumers in southern europe: The case of friuli V.G. (NE-Italy) during early and central middle ages.

7. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.

8. The Surgical Management of Tuberculous Lower Ureteric Stricture.

11. Selective Inhibition of IgE versus β2-Microglobulin in Human U--266 Myeloma Cell Line Treated with T--Cell--Derived Factors.

18. Beta glucuronidase short-term immunotherapy.

19. Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma.

20. Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS).

21. Coagulopathy in CAR-T: Critical concern or mere blip?

22. Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

23. Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity.

24. The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity.

25. Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion.

26. Inter-center reproducibility of standard and advanced echocardiographic parameters in the EACVI-AFib echo registry.

27. Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells.

28. Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.

29. Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma.

30. Management of aortic valve replacement according to the gradient across symptomatic aortic valve stenosis and its prognostic impact.

31. Left ventricular function after correction of mitral regurgitation: Impact of the clipping approach.

32. Echocardiographic reference ranges for myocardial work in healthy subjects: A preliminary study.

33. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis.

34. Increased valvulo-arterial impedance differently impacts left ventricular longitudinal, circumferential, and radial function in patients with aortic stenosis: A speckle tracking echocardiography study.

35. Autoimmunity in atopic dermatitis: biomarker or simply epiphenomenon?

Catalog

Books, media, physical & digital resources